AT279041B - Verfahren zur Inaktivierung von infektiösen Mikroorganismen - Google Patents

Verfahren zur Inaktivierung von infektiösen Mikroorganismen

Info

Publication number
AT279041B
AT279041B AT590668A AT590668A AT279041B AT 279041 B AT279041 B AT 279041B AT 590668 A AT590668 A AT 590668A AT 590668 A AT590668 A AT 590668A AT 279041 B AT279041 B AT 279041B
Authority
AT
Austria
Prior art keywords
inactivation
infectious microorganisms
infectious
microorganisms
Prior art date
Application number
AT590668A
Other languages
German (de)
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AT279041B publication Critical patent/AT279041B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT590668A 1967-06-22 1968-06-20 Verfahren zur Inaktivierung von infektiösen Mikroorganismen AT279041B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1617350A DE1617350C3 (de) 1967-06-22 1967-06-22 Verfahren zur Inaktivierung von biologischem Material

Publications (1)

Publication Number Publication Date
AT279041B true AT279041B (de) 1970-02-25

Family

ID=6986788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT590668A AT279041B (de) 1967-06-22 1968-06-20 Verfahren zur Inaktivierung von infektiösen Mikroorganismen

Country Status (9)

Country Link
JP (1) JPS494932B1 (fr)
AT (1) AT279041B (fr)
BE (1) BE717053A (fr)
BR (1) BR6800054D0 (fr)
CH (1) CH562612A5 (fr)
DE (1) DE1617350C3 (fr)
FR (2) FR1588829A (fr)
IL (1) IL30206A (fr)
LU (1) LU56297A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748132A1 (de) * 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
JPS6122331U (ja) * 1984-07-16 1986-02-08 マルコン電子株式会社 回転機用コンデンサ
JPS6286707A (ja) * 1985-10-02 1987-04-21 アテシ 高電圧高エネルギ−密度コンデンサ
FR2814957B1 (fr) * 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation

Also Published As

Publication number Publication date
DE1617350B2 (de) 1979-01-11
DE1617350A1 (de) 1971-03-25
FR1588829A (fr) 1970-03-16
DE1617350C3 (de) 1979-09-06
BR6800054D0 (pt) 1973-02-13
FR8086M (fr) 1970-07-20
CH562612A5 (en) 1975-06-13
JPS494932B1 (fr) 1974-02-04
LU56297A1 (fr) 1970-01-15
IL30206A0 (en) 1968-08-22
BE717053A (fr) 1968-12-24
IL30206A (en) 1972-05-30

Similar Documents

Publication Publication Date Title
CH489538A (de) Verfahren zur Extraktion von Proteinen aus Mikroorganismen
CH460787A (de) Verfahren zur Herstellung von 1-Aralkyl-4-(thiazolyl-2)-piperazinen
CH540977A (de) Vorrichtung zur Züchtung von Mikroorganismen
AT289011B (de) Verfahren zur mikrobiologischen Herstellung von Lipase
AT279041B (de) Verfahren zur Inaktivierung von infektiösen Mikroorganismen
CH479636A (de) Verfahren zur Herstellung von Copolymerisaten
CH449043A (de) Verfahren zur Herstellung von L-Alanin
CH468981A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
CH456568A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT271356B (de) Verfahren zur Isolierung von Mikroorganismen
CH448053A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT287194B (de) Verfahren zur Herstellung von Bakterienfraktionen
AT272294B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH455743A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT270199B (de) Verfahren zur Herstellung von amorphen Copolymerisaten
AT272295B (de) Verfahren zur Herstellung von α,ω-Alkylendiaminen
CH451912A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT282194B (de) Verfahren zur Herstellung von Copolymerisaten des Tioxans
CH448050A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
CH481893A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
CH469679A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
AT255124B (de) Verfahren zur Herstellung von Mischpolymerisaten
AT255121B (de) Verfahren zur Herstellung von Copolymerisaten
CH470365A (de) Verfahren zur Herstellung von Benzolsulfonylharnstoffen
CH498465A (de) Verfahren zur Herstellung von Magnetogrammträgern

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee